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IL-1b plays a critical role in the development of atherosclerosis and other inflammatory diseases. Because of its low solubility, cholesterol crystallizes in circulation and is taken up by monocyte-derived macrophages (4-6), activating their inflammasomes to release IL-1b and other proinflammatory cytokines (7) . These molecules recruit myeloid cells to the vascular endothelium, where their cholesterol content generates obstructive lesions (8) . In atherosclerosis and other sterile inflammatory diseases, the endogenous priming signals that activate IL-1b transcription prior to inflammasome activation remain unknown.
IL-1b up-regulates chemokines that recruit neutrophils to atherosclerotic lesions (9-11). Neutrophils are implicated in disease (12, 13) , but their role in pathogenesis remains poorly understood. To combat pathogens that evade phagocytosis (14) , neutrophils release neutrophil extracellular traps (NETs) composed of decondensed chromatin and antimicrobials (15) . NETs are implicated in several inflammatory diseases (16) , but their pathogenic mechanism and role in atherosclerosis are unclear.
To examine how neutrophils respond during atherosclerosis, we investigated the effect of cholesterol crystals on human blood-derived neutrophils. Cholesterol crystals induced NET formation (NETosis) (Fig. 1, A and B) at concentrations required to activate the inflammasome ( fig. S1 , A and B) (7) as efficiently as microbes (14) , triggering a reactive oxygen species (ROS) burst ( fig. S1C ) and neutrophil elastase (NE) translocation to the nucleus ( fig. S1D ), a critical step for NETosis (17) . NETosis depended on ROS, as it was blocked by diphenylene iodonium [DPI; an inhibitor of reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase] or an inhibitor (NEi) of the neutrophil-specific proteases NE and proteinase 3 (PR3) (17) but not by Cl-amidine, which inhibits peptidylarginine deiminase (PAD) enzymes implicated in NETosis (18) (Fig. 1, A  and B, and fig. S1E ). Consistently, DPI or NEi blocked NE translocation to the nucleus driven by cholesterol ( fig. S1D) (19) .
Next, we examined whether NETs form during atherosclerosis. Previous studies reported the presence of NETs in lesions but showed intact neutrophils with condensed nuclei (20) or luminar rather than lesion-associated neutrophils in the absence of specific NET markers (21) . We detected NETs as large amorphous extracellular structures in atherosclerotic lesions from apolipoprotein E (ApoE)-deficient mice that were placed on a high-fat diet (HFD) for 8 weeks to induce hypercholesterolemia (Fig. 1C) . NETs formed in cholesterol-rich areas but were absent from adjacent adventitia ( fig. S2A ). To block NETosis in vivo, we crossed ApoE-deficient animals with mice deficient in PR3 and NE, because deleting both enzymes may abrogate NETosis more effectively (22) . NETs were completely absent in lesions of ApoE/PR3/NE-deficient mice after 8 weeks on HFD (Fig. 1C) and ApoE-deficient mice after 6 weeks on HFD receiving deoxyribonuclease (DNase), which degrades NETs (23) ( fig. S2B ).
Subsequently, we assessed the effect of NET deficiency on atherosclerosis. When placed on HFD, ApoE-and ApoE/PR3/NE -deficient mice exhibited similar weight gain ( fig. S3A ) and blood cholesterol, triglyceride, and low-density lipoprotein (LDL) concentrations ( fig. S3B ). Analysis of aortic root cross sections showed that the two groups were modestly different after 4 weeks on HFD ( fig. S3 , C and D), suggesting that NETs did not play a critical role early during atherogenesis. However, after 8 weeks on HFD, ApoE/PR3/NEdeficient mice exhibited a factor of 3 reduction in plaque size relative to ApoE-deficient controls (Fig. 2, A and B ). These differences were also reflected by en face analysis of intact aortas (fig. S3, E and F). DNase injections into ApoE-deficient mice on HFD for 6 weeks resulted in a comparable factor of 3 reduction in lesion size, which excludes the possibility that the proteases played NETindependent roles (Fig. 2 , C and D). Lesion growth was unaffected by DNase in ApoE/PR3/NE-deficient mice that lack NETs.
NET-deficient mice exhibited a reduction in lesion growth that was comparable to mice lacking NLRP3 or the IL-1 receptor; this finding suggested that NETs may drive atherosclerosis by modulating cytokine production. Indeed, IL-1a, IL-1b, and IL-6 were elevated in the plasma of ApoE-deficient animals after 8 weeks on HFD but were largely absent in ApoE/PR3/NE-deficient mice (Fig. 3A and fig.  S4A ). After 16 weeks on HFD, IL-1a but not IL1b concentrations were still elevated in ApoEdeficient controls relative to NET-deficient animals ( fig. S4B ). DNase administration abrogated plasma cytokine concentrations in ApoE-deficient controls but had no effect on ApoE/PR3/NE-deficient mice ( fig. S4C) . Furthermore, IL-1b staining, which detects both immature and mature protein, was prominent in lesions from ApoE-deficient mice but was absent in ApoE/PR3/NE knockout animals and colocalized with NETs and macrophages ( Fig. 3B and fig. S4D ). By contrast, IL-1b concentrations were similar in the spleen or in blood mononuclear cells ( fig. S4E ), although we cannot exclude that systemic cytokines were not produced differentially elsewhere. In addition, IL-1b mRNA concentrations were significantly reduced in aortas from ApoE/PR3/NE-deficient mice (Fig. 3C) . Together, these data indicate that NE and PR3 were not mediating IL-1b maturation posttranslationally, and instead suggest that NETs are essential for the transcription of proinflammatory cytokines.
The requirement of NETs for cytokine production, and the proximity of NETs to macrophages (Fig. 3D ) and IL-1b in lesions (Fig. 3B) , prompted us to examine whether NETs regulate cytokine production by macrophages. We prepared NETs from cholesterol crystal-stimulated neutrophils ( fig. S5A) (24) and investigated their effects on CD14-purified, blood-derived human monocytes in vitro. Stimulation with NETs or cholesterol crystals separately yielded minor increases in IL-1b and IL-6 concentrations in culture supernatants ( Fig. 3E and fig. S5B ). In contrast, monocytes released substantial cytokine concentrations when pretreated with NETs and subsequently stimulated with cholesterol crystals (Fig. 3E) . By comparison, neutrophils were not a major source of cytokines, as they released negligible concentrations in response to cholesterol crystals ( fig.  S5C ). Degradation of NETs by DNase treatment ( fig. S4A ) abrogated cytokine release ( fig. S5B ), indicating the requirement for a DNA moiety. Consistently, an oligonucleotide (ODN) antagonist of the pattern recognition DNA receptor Tolllike receptor 9 (TLR9) significantly reduced cytokine release in NET-treated monocytes, but not monocytes primed with bacterial lipopolysaccharide (LPS) (Fig. 3E) . Because TLR9 is not expressed in monocytes, these data suggest that DNA is important for monocyte activation but that its detection is mediated via other DNA receptors blocked by ODN. Blocking with oligonucleotide did not fully inhibit IL-1b induction, so we reasoned that additional non-DNA NET factors contribute to monocyte activation. Blocking TLR2 and TLR4, which bind endogenous proteins, for single comparison and two-way analysis of variance (ANOVA) followed by Sidak's multiple comparison post test for multiple comparisons: **P < 0.01, ***P < 0.001, ****P < 0.0001; n.s., not significant. decreased IL-1b release and synergized with oligonucleotide inhibition, indicating that both protein and DNA moieties are important in NETmediated priming ( fig. S5D ). The complete abrogation by DNase suggests that the association of these moieties is critical. In the absence of cholesterol, NETs did not induce substantial inflammasome activation, as reflected by the lack of caspase-1 and IL-1b maturation (Fig. 3F ), which were observed only upon costimulation with cholesterol crystals. Stimulation with NETs also upregulated monocytic cytokine transcripts (Fig. 3G) . These data are consistent with NETs providing priming signals in atherosclerosis. IL-1b up-regulates the T cell-derived cytokine IL-17, which drives the chemokines CXCL1 and CXCL2 to promote neutrophil recruitment during inflammation (9, 25) . Both groups of mice exhibited comparable numbers of T cells (figs. S6 and S7), but aortas from ApoE/PR3/NE-deficient mice on 8-week HFD contained few IL-17 + T cells relative to ApoE-deficient controls (Fig. 4, A and  B) . IL-17-producing T cells could not be detected in aortas of ApoE −/− animals after 4 weeks on HFD ( fig. S8, A and B) , which suggests that strong T cell activation does not precede NET-driven inflammation. The blood of NET-deficient mice did not exhibit alterations in immune cell populations, and circulating IL-17 + T cells were absent in both groups (figs. S9 and S10). The spleen and lymph nodes contained a small IL-17 + gd T cell population but no IL-17 + ab T cells (figs. S11 and S12, A and B). Furthermore, concentrations of IL-17A, CXCL1, CXCL2, and the monocyte chemokine CCL2 were also significantly reduced in aortas of ApoE/PR3/NEdeficient mice (Fig. 4C) . Consistently, we counted fewer neutrophils in lesions and adventitia of ApoE/PR3/NE-deficient mice, by microscopy ( Fig.  4D) and fluorescence-activated cell sorting (FACS) (fig. S7B) . Although both groups contained a comparable makeup of immune cells ( fig. S7A ), ApoE/ PR3/NE-deficient animals had significantly lower total immune cell counts per aorta ( fig. S7B) , consistent with reduced inflammation and smaller lesions. Adhesion molecule transcripts were similar in aortas from both groups, but differences may be difficult to detect because of the patchy lesion morphology ( fig. S12C) .
Neutrophil recruitment was comparable in the skin of wild-type and PR3/NE-deficient animals treated with Aldara imiquimod (fig. S13, A and B) , which drives IL-1 exogenously to promote sterile psoriatic inflammation (26) . Hence, the reduction in neutrophil recruitment in ApoE/PR3/NEdeficient lesions was not due to intrinsic defects in neutrophil chemotaxis or extravasation. Therefore, NET-mediated priming of macrophages promotes a self-amplifying IL-1-IL-17 cascade and uncovers a mechanism for neutrophils to regulate T helper 17 (T H 17) cells that sustains chronic sterile inflammation ( fig. S13C) .
Our data reveal a requirement of NETs as priming cues in vivo and show that NETs are substantially more potent in priming cytokines than in activating the inflammasome. Although other endogenous molecules such as oxidized LDL can prime in vitro, their importance in vivo has not been demonstrated (7, 27) . Interestingly, antibodies against oxidized LDL in lesions recognize oxidized phospholipids that suppress inflammation (28) . NETosis may prime more efficiently than necrosis (29, 30) , as it effectively exposes highly decondensed and proinflammatory DNA (31) .
A recent study using Cl-amidine proposed that NETs drive a plasmacytoid dendritic cell (pDC)-derived interferon-a (IFN-a) autoimmune cascade in atherosclerosis via TLR9 ligation (20) . However, TLR9 deficiency has little effect on atherogenesis (32) Moreover, PAD enzymes are expressed in many cell types (33) and were dispensable for NETosis triggered by cholesterol crystals (fig. S1E ). Whereas IFN signaling down-regulates IL-1b expression, genetic ablation of the IFNa/b receptor yields a modest 25% decrease in lesion size (34) because IFNs may contribute to pathogenesis via the upregulation of caspases (3, 35, 36) .
NET priming may drive inflammation in other NET-associated diseases such as cystic fibrosis and rheumatoid arthritis (24, 37) . In contrast to the broad importance of IL-1 and IL-17, NETs play more specialized roles in immune defense (14) and NET-deficient individuals are primarily susceptible to localized fungal infection (38) . Hence, blocking NETosis or degrading NETs may help to treat inflammatory diseases. 2) . In rhesus monkeys, vaccine protection has been reported against neutralization-sensitive viruses (3), but these data failed to predict protective efficacy in humans (4), which suggests the importance of using neutralization-resistant virus challenges for preclinical evaluation of HIV-1 and SIV vaccine candidates. We previously showed that priming with adenovirus vectors and boosting with poxvirus vectors expressing Env, Gag, and Pol resulted in a reduced per-exposure acquisition risk after challenges with neutralization-resistant SIVmac251, but the majority of these animals were infected at the end of the challenge series (5, 6) . To augment antibody responses, we evaluated the immunogenicity and protective efficacy of priming with adenovirus vectors and boosting with adjuvanted Env gp140 protein against SIVmac251 and SHIV-SF162P3 challenges in rhesus monkeys.
We immunized 32 adult rhesus monkeys (Macaca mulatta) that did not express the protective major histocompatibility complex class I alleles Mamu-A*01, Mamu-B*08, or Mamu-B*17 with adenovirus serotype 26 (Ad26) vectors (7) expressing SIVsmE543 Env/Gag/Pol antigens (5) followed by either SIVmac32H Env gp140 protein (8) (Ad/Env; n = 12) or Ad35 vectors (9) expressing SIVsmE543 Env/Gag/Pol antigens (Ad Alone; n = 12), and a control group received sham vaccines (Sham; n = 8). Animals in the Ad/Env group were primed with 3 × 10 10 viral particles (vp) Ad26-Env/Gag/Pol vectors (10 10 vp per vector) by the intramuscular route at weeks 0 and 24 and were boosted with 0.25 mg Env gp140 with AS01B Adjuvant System at weeks 52, 56, and 60. Animals in the Ad Alone group were primed with 3 × 10 10 vp Ad26-Env/Gag/Pol vectors at weeks 0 and 24 and were boosted with 3 × 10 10 vp Ad35-Env/Gag/Pol at week 52. One control animal died before challenge for reasons unrelated to the study protocol and was excluded from the analysis.
Binding antibody responses to heterologous SIVmac239 Env gp140 were detected by enzymelinked immunosorbent assay (ELISA) (10) in all vaccinated animals after Ad26 priming at weeks 4 and 28 (Fig. 1A) . In the Ad/Env group, ELISA end-point titers increased from 5.3 logs at week 28 to 6.4 logs after the SIV Env gp140 boosts at week 64 (P < 0.0001) (Fig. 1A) , which confirmed that the Env boost effectively augmented Ad26-primed antibody responses. Neutralizing antibody (NAb) responses assessed in the TZM-bl cell line (11) against tier 1 heterologous SIVmac251_TCLA.15 and homologous SIVsmE660 CP3C-P-A8 viruses also increased significantly after SIV Env gp140 boosting ( fig. S1 ). NAb responses against tier 2 viruses were borderline ( fig. S1 ).
In addition to neutralization, antibodies mediate a wide variety of additional antiviral functions through their ability to interact with Fc receptors, complement, and lectin-like proteins
